Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma
Table 3
Univariate and multivariate prediction of progression-free survival.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Univariate and multivariate prediction of progression-free survival.